Decheng Capital
Menlo Park, Californiadecheng.com
Overview
Decheng Capital is a venture capital firm that provides capital and strategic support to early-stage life science companies and growth-stage healthcare companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Remix Therapeutics | Jun 2026 | Private Placement | Lead |
| Serapha Bio | Jun 2026 | Series A | Co-investor |
| Cellares | Jun 2026 | Series D | Co-investor |
| Vivacta Biotechnology (Shanghai) Co., Ltd. | Apr 2026 | Series A | Lead |
| Syneron Bio | Mar 2026 | Series B | Lead |
Key People
Dan Zabrowski
Venture Partner
Dayton Misfeldt
Partner
Nick Pliam
Partner
Qiang Xu
Partner
Michael Notaras
Vice President - Biotech Public Equities Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
